Abbvie Inc
NYSE:ABBV
Abbvie Inc
Total Liabilities & Equity
Abbvie Inc
Total Liabilities & Equity Peer Comparison
Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abbvie Inc
NYSE:ABBV
|
Total Liabilities & Equity
$134.7B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
18%
|
CAGR 10-Years
17%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Total Liabilities & Equity
$62.1B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
0%
|
CAGR 10-Years
11%
|
|
Amgen Inc
NASDAQ:AMGN
|
Total Liabilities & Equity
$97.2B
|
CAGR 3-Years
16%
|
CAGR 5-Years
8%
|
CAGR 10-Years
4%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Total Liabilities & Equity
$22.7B
|
CAGR 3-Years
25%
|
CAGR 5-Years
29%
|
CAGR 10-Years
26%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Total Liabilities & Equity
$33.1B
|
CAGR 3-Years
24%
|
CAGR 5-Years
23%
|
CAGR 10-Years
27%
|
|
Seagen Inc
NASDAQ:SGEN
|
Total Liabilities & Equity
$3.6B
|
CAGR 3-Years
7%
|
CAGR 5-Years
18%
|
CAGR 10-Years
22%
|
See Also
What is Abbvie Inc's Total Liabilities & Equity?
Total Liabilities & Equity
134.7B
USD
Based on the financial report for Dec 31, 2023, Abbvie Inc's Total Liabilities & Equity amounts to 134.7B USD.
What is Abbvie Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
17%
Over the last year, the Total Liabilities & Equity growth was -3%. The average annual Total Liabilities & Equity growth rates for Abbvie Inc have been -4% over the past three years , 18% over the past five years , and 17% over the past ten years .